AI assistant
REVVITY, INC. — Director's Dealing 2022
Dec 16, 2022
30616_dirs_2022-12-16_e8c23f84-6719-4502-9089-f0c227b2b20d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PERKINELMER INC (PKI)
CIK: 0000031791
Period of Report: 2022-12-15
Reporting Person: Okun Andrew (Please See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-12-15 | Common Stock | M | 4800 | $92.09 | Acquired | 11191 | Direct |
| 2022-12-15 | Common Stock | M | 3350 | $96.06 | Acquired | 14541 | Direct |
| 2022-12-15 | Common Stock | S | 4995 | $140.82 | Disposed | 9546 | Direct |
| 2022-12-15 | Common Stock | S | 3155 | $141.21 | Disposed | 6391 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-12-15 | NQ Stock Option (right to buy) | $92.09 | M | 4800 | Disposed | 2026-02-05 | Common Stock (4800) | Direct |
| 2022-12-15 | NQ Stock Option (right to buy) | $96.06 | M | 3350 | Disposed | 2027-01-30 | Common Stock (3350) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 8 | Indirect |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Okun on November 15, 2022.
F2: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $140.04 to $141.01. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F3: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $141.04 to $141.77. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F4: This option became exercisable in three equal annual installments beginning on February 5, 2020, which was the first anniversary of the date on which the option was granted.
F5: This option became exercisable in three equal annual installments beginning on January 30, 2021, which was the first anniversary of the date on which the option was granted.